These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Delineating the molecular basis of the inactivity of tissue inhibitor of metalloproteinase-2 against tumor necrosis factor-alpha-converting enzyme. Lee MH, Rapti M, Murphy G. J Biol Chem; 2004 Oct 22; 279(43):45121-9. PubMed ID: 15308656 [Abstract] [Full Text] [Related]
7. Dynamic interdomain interactions contribute to the inhibition of matrix metalloproteinases by tissue inhibitors of metalloproteinases. Remacle AG, Shiryaev SA, Radichev IA, Rozanov DV, Stec B, Strongin AY. J Biol Chem; 2011 Jun 10; 286(23):21002-12. PubMed ID: 21518756 [Abstract] [Full Text] [Related]
11. Structure-function relationships in the tissue inhibitors of metalloproteinases. Willenbrock F, Murphy G. Am J Respir Crit Care Med; 1994 Dec 10; 150(6 Pt 2):S165-70. PubMed ID: 7952654 [Abstract] [Full Text] [Related]
12. Matrix metalloproteinase-10/TIMP-2 structure and analyses define conserved core interactions and diverse exosite interactions in MMP/TIMP complexes. Batra J, Soares AS, Mehner C, Radisky ES. PLoS One; 2013 Dec 10; 8(9):e75836. PubMed ID: 24073280 [Abstract] [Full Text] [Related]
14. Characterization of C-terminally truncated human tissue inhibitor of metalloproteinases-4 expressed in Pichia pastoris. Stratmann B, Farr M, Tschesche H. Biol Chem; 2001 Jun 10; 382(6):987-91. PubMed ID: 11501766 [Abstract] [Full Text] [Related]
15. Crystal structures of MMPs in complex with physiological and pharmacological inhibitors. Maskos K. Biochimie; 2005 Jun 10; 87(3-4):249-63. PubMed ID: 15781312 [Abstract] [Full Text] [Related]
16. Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro. Hirata M, Sato T, Tsumagari M, Shimada A, Nakano H, Hashizume K, Ito A. Biol Reprod; 2003 Apr 10; 68(4):1276-81. PubMed ID: 12606436 [Abstract] [Full Text] [Related]
17. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD, Overall CM. Cancer Res; 2001 May 01; 61(9):3610-8. PubMed ID: 11325829 [Abstract] [Full Text] [Related]
18. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP). Worley JR, Thompkins PB, Lee MH, Hutton M, Soloway P, Edwards DR, Murphy G, Knäuper V. Biochem J; 2003 Jun 15; 372(Pt 3):799-809. PubMed ID: 12630911 [Abstract] [Full Text] [Related]
19. Dynamic characterisation of the netrin-like domain of human type 1 procollagen C-proteinase enhancer and comparison to the N-terminal domain of tissue inhibitor of metalloproteinases (TIMP). Williamson RA, Panagiotidou P, Mott JD, Howard MJ. Mol Biosyst; 2008 May 15; 4(5):417-25. PubMed ID: 18414739 [Abstract] [Full Text] [Related]
20. Directed evolution of the metalloproteinase inhibitor TIMP-1 reveals that its N- and C-terminal domains cooperate in matrix metalloproteinase recognition. Raeeszadeh-Sarmazdeh M, Greene KA, Sankaran B, Downey GP, Radisky DC, Radisky ES. J Biol Chem; 2019 Jun 14; 294(24):9476-9488. PubMed ID: 31040180 [Abstract] [Full Text] [Related] Page: [Next] [New Search]